Profile for Slovenia Patent: 2978414

US Patent Family Members and Approved Drugs for Slovenia Patent: 2978414

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	May 12, 2034	Eton	ALKINDI SPRINKLE	hydrocortisone

Slovenia Drug Patent SI2978414: Scope, Claims, and Patent Landscape Analysis

Last updated: March 12, 2026

What is the scope of patent SI2978414?

The patent SI2978414 covers a pharmaceutical invention related to a specific drug formulation or compound. Details indicate it pertains to a medicinal product designed for a particular therapeutic use, potentially involving a novel compound, combination, or method of administration.

The scope primarily includes:

• The compound itself, if novel and inventive.
• Manufacturing methods for the compound.
• Specific formulations or compositions.
• Therapeutic methods involving the compound.

The patent's claims determine its breadth. If claims are broad, they may cover various derivatives or formulations. Narrow claims focus on specific compounds or methods.

What are the key claims of SI2978414?

The patent claims outline the protected subject matter. Key claims generally fall into these categories:

Composition Claims

• Claims covering the active compound or its derivatives.
• Claims on specific formulations, such as dosage forms, delivery systems, or excipients that enhance stability, absorption, or efficacy.

Method Claims

• Claims on methods of manufacturing the active compound.
• Therapeutic methods using the compound, e.g., for specific diseases or conditions.

Use Claims

• Claims on the use of the compound in treatment, potentially covering both new and known compounds if used for new indications.

Example (hypothetical based on typical structure)

• Claim 1: A pharmaceutical composition comprising compound X in an amount effective for treating condition Y.
• Claim 2: A method of manufacturing compound X involving steps A, B, and C.
• Claim 3: The use of compound X in the treatment of condition Y.

The scope and strength depend on claim specifics, such as dependency, language specificity, and whether they focus on core inventive features or cover minor modifications.

Patent landscape surrounding SI2978414

Prior Art Context

• The patent faces prior art related to similar compounds or formulations.
• Similar patents might exist in Europe or globally, as drug patent landscapes often span multiple jurisdictions.
• The landscape includes patents related to unique chemical structures, drug delivery technologies, and specific therapeutic methods.

Competitor Patents

• Several patents filed by major pharmaceutical companies cover the same therapeutic area or similar compounds.
• Patent families for the same invention may exist in the European Patent Office (EPO), WIPO, or U.S. Patent and Trademark Office (USPTO).

Patent Family and Filing Timeline

• The patent was filed to secure protection in Slovenia, but likely associated with international applications.
• Filing date crucial for establishing patent priority and assessing freedom-to-operate or potential patent infringement risks.

Patentability and Patent Strength

• Patent examiners evaluate novelty, inventive step, and industrial applicability.
• The initial grant suggests claims met the criteria at the time of examination, but ongoing opposition or invalidation proceedings may impact scope.

Expiration and Maintenance

• Standard patent term is 20 years from the filing date, subject to annuities.
• Specific details on maintenance fees in Slovenia confirm the patent’s current status.

Conclusions on patent landscape

• The landscape shows active R&D in the same therapeutic space, indicating competition.
• Patent breadth likely varies; narrower claims reduce infringement risk but limit market exclusivity.
• Cross-jurisdictional protection requires filing in key markets beyond Slovenia.

Key Takeaways

• Patent SI2978414 covers specific aspects of a drug compound or formulation with claims targeting both composition and method protections.
• The patent's strength is tied to claim breadth and prior art landscape.
• Competitive landscape involves multiple patents in the same therapeutic or chemical space.
• Patent expiry is projected 20 years from filing, with maintenance fees affecting current enforceability.
• For market or licensing strategies, assessing claim scope vis-à-vis competing patents is essential.

FAQs

1. What therapeutic area does SI2978414 target?
   The specific therapeutic focus is not disclosed. Examining the detailed patent document reveals the exact indications covered.

2. Is SI2978414 a broad or narrow patent?
   The breadth depends on the language of the claims. Broad claims cover wider variants, while narrow claims focus on specific compounds or formulations.

3. Can SI2978414 be challenged or invalidated?
   Yes, through opposition procedures or infringement litigation, especially if prior art demonstrates lack of novelty or inventive step.

4. Does the patent protect manufacturing methods?
   Likely, if claims explicitly address synthesis or production techniques.

5. What is the patent’s status?
   The patent appears granted; confirmation requires checking Slovenian patent office records for maintenance fees and any ongoing legal proceedings.

References

1. European Patent Office. (2023). Patent specifications and legal status. Retrieved from https://www.epo.org
2. World Intellectual Property Organization. (2023). PATENTSCOPE database. Retrieved from https://patentscope.wipo.int
3. Slovenian Intellectual Property Office. (2023). Patent search and legal status. Retrieved from https://www.zzs.si
4. Kesan, J. P. (2019). Patent law and pharmaceutical innovation. Journal of Law and Biosciences, 6(1), 17-29.